Clinical trial · Observational
Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors
NCT02303015CI-TRIAL-00071559completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to identify genetic variations in survivors of testicular cancer and connect these variations to differences in risks of late effects.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Germ Cell Cancer | Malignant Germ Cell Tumor | ALIAS | 0.90 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Danish germ cell cancer patients
- description
- Danish patients with germ cell cancer diagnosed from 1984 to 2007.
Primary outcomes (1)
- measure
- Renal toxicity (Identify genetic variations predicting renal toxicity)
- timeFrame
- 1 year
- description
- Identify genetic variations predicting renal toxicity.
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 15 Years
Show eligibility criteria text
Inclusion Criteria: * Danish citizen * Diagnosed with germ cell cancer from 1984 to 2007 * Treated initially at a Danish hospital * Treated with standard treatment regimens. Exclusion Criteria: * Treated initially at a foreign hospital
References
Publications (0)
Data not yet available
No reference posted for this study.